no approval yet in china ??, page-2

There appears to be no approval risk whatsoever in China or Europe. The Hep B vaccine will also be distributed in Europe by Berna Biotech AG (Switzerland) An earlier inferior earlier generation vaccine is already distributed by Berna and approval of Scigens vaccine in Europe will open up another huge market. This is not their only product or contract and the action yesterday was really the market waking up to the existing worth of this Company.(and its furure prospects)
The risk to SIE at the moment is production as the production facility they are building for themselves in Israel will not be finished till next year. But remember Bioton (with manufacturing capacity) has a 24% stake in the Company.